Research progress and applications of nanobody in human infectious diseases
Infectious diseases, caused by pathogenic microorganisms, are capable of affecting crises. In addition to persistent infectious diseases such as malaria and dengue fever, the vicious outbreaks of infectious diseases such as Neocon, Ebola and SARS-CoV-2 in recent years have prompted the search for mo...
Main Authors: | Yaxian Mei, Yuanzhi Chen, Jwala P. Sivaccumar, Zhiqiang An, Ningshao Xia, Wenxin Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.963978/full |
Similar Items
-
Editorial: Nanobody-based cancer immunotherapy and immunoimaging
by: Mahdie Jafari, et al.
Published: (2023-05-01) -
NbX: Machine Learning-Guided Re-Ranking of Nanobody–Antigen Binding Poses
by: Chunlai Tam, et al.
Published: (2021-09-01) -
Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus Infection
by: Yoshikazu Yuki, et al.
Published: (2022-12-01) -
Nanobody Paratope Ensembles in Solution Characterized by MD Simulations and NMR
by: Monica L. Fernández-Quintero, et al.
Published: (2022-05-01) -
Generation and characterization of antagonistic anti-human CD39 nanobodies
by: Stephan Menzel, et al.
Published: (2024-03-01)